// App-Quantinova.ai

P940 : SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-4 STUDY

Researchers

Presenter

  • Attaya Suvannasankha

Principal Investigators

  • Nizar Bahlis

  • Suzanne Trudel

  • Katja Weisel

  • Christian Koenecke

  • Albert Oriol

  • Peter M Voorhees

  • Arnzazu Alonso Alonso

  • Natalie S Callander

  • Nishitha Reddy

  • Nashita Patel

  • Roxanne C Jewell

  • Xiangdong Zhou

  • Ira Gupta

  • Ajay K Nooka

Medical Centers

  • GlaxoSmithKline,Philadelphia, PA,Verenigde Staten

  • GlaxoSmithKline, PA.

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Hannover Medical School, Clinic for Hematolog

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Hannover Medical School, Clinic for Hematology, Hemostasis, Oncology and Stem Cell Transplantation,Hannover,Deutschland

  • GlaxoSmithKline, Upper Providence, PA, United States.

  • Carbone Cancer Center, University of Wisconsin,Madison, WI,United States

  • Institut Català d'Oncologia and Institut Jos

  • Hannover Medical School - Department of Haematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover,

  • Indiana University Simon Cancer Center and Roudebush VAMC,Indianapolis, IN,Vereinigte Staaten

  • Winship Cancer Institute, Emory University Hospital,Atlanta, GA,Vereinigte Staaten

  • University Medical Center Utrecht,

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • GlaxoSmithKline,Philadelphia, PA,États-unis

  • GlaxoSmithKline, Upper Providence, PA, United States.

  • GlaxoSmithKline, Research Triangle Park, NC, United States.

  • Hospit

  • GlaxoSmithKline,Research Triangle Park, NC,Estados Unidos

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Winship Cancer Institute of Emory University,Atlanta, GA,Vereinigte Staaten

  • Co., Inc.,Kenilworth, NJ,États-unis

  • GlaxoSmithKline, Research Triangle Park, NC

  • Levine Cancer Institute, Atrium Health, Charlotte, NC

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Indiana University Simon Cancer Center and Roudebush VAMC,Indianapolis, IN,Vereinigte Staaten

  • GlaxoSmithKline, Research Triangle Park, NC

  • GlaxoSmithKline, Research Triangle Park, NC, United States.

  • Co., Inc.,Kenilworth,Stati Uniti

  • Hannover Medical School - Department of Haematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover,

  • Merck &

  • Institut Catala dOncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain

  • Indiana University Simon Cancer Center and R

  • Instituto de Investigación Biomédica de Salamanca and Centro de Investigación del Cáncer, Hospital Universitario

  • Levine Cancer Institute/Atrium Health,Charlotte,Verenigde Staten

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Hospital Universitario Quiron Madrid, Madrid, Spain

  • Co., Inc.,Kenilworth,Vereinigte Staaten

  • Institut Catala dOncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain

  • GlaxoSmithKline,Philadelphia, PA,Verenigde Staten

  • GlaxoSmithKline,Upper Providence, PA,Estados Unidos

  • GlaxoSmithKline, Upper Providence, PA

  • GlaxoSmithKline, Philadelphia, PA, United States,

  • GlaxoSmithKline,Philadelphia, PA,États-unis

  • Merck &amp

  • Carbone Cancer Center, University of Wisconsin,Madison, WI,United States

  • Hospital Universitario Quiron Madrid, Madrid, Spain

  • GlaxoSmithKline,Upper Providence, PA,Estados Unidos

  • Hospital Universitario Quirónsalud Madrid,Madrid,España

  • Co., Inc.,Kenilworth,Vereinigte Staaten

  • GlaxoSmithKline, Research Triangle Park, NC

  • Southern Alberta Cancer Research Institute, University of Calgary, Calgary, AB, Canada

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Instituto de Investigación Biomédica de Salamanca and Centro de Investigación del Cáncer, Hospital Universitario

  • GlaxoSmithKline,Upper Providence, PA,Estados Unidos

  • Levine Cancer Institute, Atrium Health, Charlotte, NC

  • Winship Cancer Institute, Emory University Hospital,Atlanta, GA,États-unis

  • Levine Cancer Institute/Atrium Health,Charlotte,Verenigde Staten

  • GlaxoSmithKline,Philadelphia, PA,États-unis

  • Merck & Co., Inc., Kenilworth, NJ, United States,

  • Co., Inc.,Kenilworth,Estados Unidos

  • Levine Cancer Institute, Atrium Health, Charlotte, NC

  • Indiana University Simon Cancer Center and Roudebush VAMC,Indianapolis, IN,Vereinigte Staaten

  • GlaxoSmithKline, Research Triangle Park, NC, United States.

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Hospital Universitario Quiron Madrid, Madrid, Spain

  • GlaxoSmithKline, Upper Providence, PA, United States.

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Hospital Universitario Quiron Madrid, Madrid, Spain

  • Levine Cancer Institute, Atrium Health, Charlotte, NC

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Indiana University Simon Cancer Center and Roudebush VAMC,Indianapolis, IN,Vereinigte Staaten

  • Hospital Universitario Quirónsalud Madrid,Madrid,España

  • Arnie Charbonneau Cancer Institute,University of Calgary,Calgary,Kanada

  • Winship C

  • Winship Cancer Institute, Emory University,Atlanta,États-unis

  • Carbone Cancer Center, University of Wisconsin,Madison, WI,Estados Unidos

  • Arnie Charbonneau Cancer Research Institute, University

  • Carbone Cancer Center, University of Wisconsin,Madison, WI,Estados Unidos

  • Hospital Universitario Quirónsalud Madrid,Madrid,Espagne

  • Instituto de Investigación Biomédica de Salamanca and Centro de Investigación del Cáncer, Hospital Universitario

  • Institut Catala dOncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain

  • Carbone Cancer Center, University

  • Winship Cancer Institute, Emory University,Atlanta,États-unis

  • Carbone Cancer Center, University of Wisconsin,Madison, WI,Estados Unidos

Locations

  • United States

  • Canada

  • Germany

  • Spain

  • Mexico

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • GSK2857916

  • Pembrolizumab

Outcome

  • N/A


Study Design

  • Pharmacokinetics

  • Open Label

  • Single Arm

Phase

  • I/II

Study Id's

  • NCT03848845

Sponsors

  • N/A

Result

  • N/A